These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 21449214
1. Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells. Chen XR, Lu R, Dan HX, Liao G, Zhou M, Li XY, Ji N. Int J Oral Sci; 2011 Jan; 3(1):34-42. PubMed ID: 21449214 [Abstract] [Full Text] [Related]
2. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells. Ji N, Jiang L, Deng P, Xu H, Chen F, Liu J, Li J, Liao G, Zeng X, Lin Y, Feng M, Li L, Chen Q. J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776 [Abstract] [Full Text] [Related]
7. Anti‑proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF‑β1/p53 signaling pathway. Li Q, Ma Y, Liu XL, Mu L, He BC, Wu K, Sun WJ. Oncol Rep; 2020 Nov; 44(5):2093-2107. PubMed ID: 32901874 [Abstract] [Full Text] [Related]
8. Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor. Singh T, Gupta NA, Xu S, Prasad R, Velu SE, Katiyar SK. Oncotarget; 2015 Aug 28; 6(25):21268-82. PubMed ID: 26020804 [Abstract] [Full Text] [Related]
9. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. Ishitsuka K, Hideshima T, Hamasaki M, Raje N, Kumar S, Hideshima H, Shiraishi N, Yasui H, Roccaro AM, Richardson P, Podar K, Le Gouill S, Chauhan D, Tamura K, Arbiser J, Anderson KC. Blood; 2005 Sep 01; 106(5):1794-800. PubMed ID: 15870175 [Abstract] [Full Text] [Related]
10. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors. Leeman-Neill RJ, Cai Q, Joyce SC, Thomas SM, Bhola NE, Neill DB, Arbiser JL, Grandis JR. Clin Cancer Res; 2010 May 01; 16(9):2571-9. PubMed ID: 20388852 [Abstract] [Full Text] [Related]
12. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells. Yang J, Zou Y, Jiang D. Int J Mol Med; 2018 Apr 01; 41(4):1845-1854. PubMed ID: 29393336 [Abstract] [Full Text] [Related]
13. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway. Kaushik G, Kwatra D, Subramaniam D, Jensen RA, Anant S, Mammen JM. Am J Surg; 2014 Dec 01; 208(6):995-1002; discussion 1001-2. PubMed ID: 25450590 [Abstract] [Full Text] [Related]
14. Honokiol inhibits androgen receptor activity in prostate cancer cells. Hahm ER, Karlsson AI, Bonner MY, Arbiser JL, Singh SV. Prostate; 2014 Apr 01; 74(4):408-20. PubMed ID: 24338950 [Abstract] [Full Text] [Related]
15. Antitumor activity of 4-O-Methylhonokiol in human oral cancer cells is mediated via ROS generation, disruption of mitochondrial potential, cell cycle arrest and modulation of Bcl-2/Bax proteins. Xiao S, Chen F, Gao C. J BUON; 2017 Apr 01; 22(6):1577-1581. PubMed ID: 29332355 [Abstract] [Full Text] [Related]
17. Kochia scoparia induces apoptosis of oral cancer cells in vitro and in heterotopic tumors. Han HY, Lee HE, Kim HJ, Jeong SH, Kim JH, Kim H, Ryu MH. J Ethnopharmacol; 2016 Nov 04; 192():431-441. PubMed ID: 27616033 [Abstract] [Full Text] [Related]
18. Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL-6/Stat3 signaling. Chang MT, Lee SP, Fang CY, Hsieh PL, Liao YW, Lu MY, Tsai LL, Yu CC, Liu CM. Environ Toxicol; 2018 Nov 04; 33(11):1105-1112. PubMed ID: 30076764 [Abstract] [Full Text] [Related]
19. Downregulation of STAT3 and activation of MAPK are involved in the induction of apoptosis by HNK in glioblastoma cell line U87. Zhang Y, Ren X, Shi M, Jiang Z, Wang H, Su Q, Liu Q, Li G, Jiang G. Oncol Rep; 2014 Nov 04; 32(5):2038-46. PubMed ID: 25175884 [Abstract] [Full Text] [Related]